Health Observatory

The Ministry of Health has approved Jardiance (Boehringer Ingelheim and Lilly) for patients with chronic kidney disease.

Boehringer Ingelheim and Lilly Alliance announced this Wednesday that the Department of Health has approved funding for the drug Jardins…

8 months ago